National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Esophageal Cancer Trial Results
Page Options
Print This Page  Print This Page
E-Mail This Document  E-Mail This Document
Browse by Cancer Type
Breast Cancer

Lung Cancer

Prostate Cancer

More Results
Search Trial Results

    Search  
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
Restructuring the NCI Clinical Trials Enterprise

Clinical Trials Reporting Program

Coordinating Center for Clinical Trials

States Requiring Coverage of Clinical Trial Costs
Related Pages
Search for Clinical Trials
NCI's PDQ® Cancer Clinical Trials Registry.

Esophageal Cancer Home Page
NCI's gateway for information about esophageal cancer.
1.  Radiofrequency Ablation Effective Against Barrett Esophagus
(Posted: 07/23/2009) - In a randomized phase II trial, radiofrequency ablation led to high rates of eradication of the cell abnormalities associated with Barrett esophagus, according to the May 28, 2009, New England Journal of Medicine.

2.  Radiation and Chemo Before Esophageal Cancer Surgery Improves Survival
(Posted: 08/21/2007) - Preoperative (neoadjuvant) use of combination chemoradiotherapy helped patients with localized esophageal cancer to live longer, according to the March 2007 Lancet Oncology.

3.  Patients With Esophageal Cancer May Be Able to Avoid Surgery
(Posted: 04/16/2007) - Patients with esophageal cancer lived just as long after receiving chemoradiation therapy alone as did those whose chemoradiation therapy was followed by surgery, according to the April 1, 2007, Journal of Clinical Oncology.

4.  New Chemotherapy Regimen Extends Survival for Patients with Resectable Gastric Cancer
(Posted: 07/12/2006) - When it comes to chemotherapy for locally invasive gastric cancer, results from an international clinical trial published in the July 6, 2006, issue of the New England Journal of Medicine suggest that timing can make all the difference.

5.  Frozen Glove Reduces Skin and Nail Damage from Docetaxel Chemotherapy
(Posted: 08/01/2005) - Patients who wore an experimental "frozen glove" to keep their hands very cold during intravenous chemotherapy with docetaxel (Taxotere®) had much less subsequent damage to the nails and skin of their hands, according to a study published in the July 1, 2005, issue of the Journal of Clinical Oncology.


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov